BioMed Research International / 2021 / Article / Tab 1 / Research Article
[Retracted] Protein Arginine Methyltransferase 5 Promotes the Migration of AML Cells by Regulating the Expression of Leukocyte Immunoglobulin-Like Receptor B4 Table 1 The characteristics of the AML patients.
Patients Sex Age (years) BM/PB FAB WBC (109 L) HB (g/L) PLT (109 L) %blasts (BM) Evaluation AML1 M 50 BM M5 145.19 60 17 67.92 Initial AML2 F 51 BM M4 1.89 85 10 46 Initial AML3 M 53 BM M5 10.11 80 65 43 Initial AML4 F 61 BM M5 2.51 61 183 73 Initial AML5 F 73 BM M5 17.68 80 80 26 Initial AML6 F 42 BM M5 4.76 123 108 87 Relapse AML7 M 35 BM M4 8.68 84 21 58.6 Relapse AML8 F 50 BM M5 1.27 51 34 89 Initial AML9 M 73 BM M4 1.21 59 44 31 Initial AML10 F 39 BM M5 36.05 106 23 39 Initial AML11 F 77 BM M5 196.96 77 32 91 Initial AML12 F 22 BM M5 39.9 97 180 84 Relapse AML13 M 59 BM M5 1.97 128 91 57 Initial AML14 F 49 BM M5 1.3 57 113 93 Relapse AML15 F 61 BM M5 25.5 56 20 39 Initial AML16 M 53 BM M5 66.12 71 10 80 Initial AML17 F 66 BM M5 4.27 119 56 21 Relapse AML18 M 23 BM M4 95.29 135 52 89 Initial AML19 F 47 BM M5 1.19 68 46 38 Initial AML20 M 56 BM M5 14.53 72 104 85 Relapse AML21 F 49 BM M5 2.05 82 21 15 Relapse AML22 M 50 BM M5 103.76 113 58 79 Relapse AML23 F 73 BM M5 19.05 26 24 14 Relapse AML24 M 39 BM M4 6.31 71 198 39 Initial AML25 M 73 BM M4 5.2 105 108 27-35 Relapse AML26 F 21 BM M4 127.64 74 143 23 Relapse AML27 F 39 BM M5 5.7 78 32 50 Relapse AML28 M 40 BM M4 38.36 89 11 36 Relapse AML29 M 23 BM M4 2.41 112 211 27 Relapse AML30 M 59 BM M5 0.18 61 60 54 Relapse